BLRX

NASDAQ HEALTHCARE

BioLineRx Ltd

$2.32

-$0.02 (-0.85%)

Live quote

52w: $2.15 – $4.56

Loading chart…

P/E Ratio—

P/B Ratio340.05

EV/EBITDA—

Debt/Equity—

ROE-11.13%

ROIC—

Revenue Growth-95.92%

Gross Margin80.51%

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.

Create a free account to add BLRX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.